<DOC>
	<DOCNO>NCT01548534</DOCNO>
	<brief_summary>The aim study increase , DHA-induced chemosensitization , activity anticancer chemotherapy patient metastatic advance breast cancer , nutritional approach marin-derived PolyUnsaturated Fatty Acids ( PUFA ) .</brief_summary>
	<brief_title>A Randomised Study Docosahexaenoic Acid ( DHA ) Metastatic Breast Cancer</brief_title>
	<detailed_description>Local relapse metastasis make breast cancer deadly disease . A major goal remain improvement treatment efficacy , mean increase toxicity tumor tissue , without additional toxicity non-tumor tissue . The literature indicate DHA sensitize breast malignant tumor , non-tumor tissue , chemotherapy radiotherapy variety mechanism . DHA enrichment tissue achieve dietary supplementation DHA-containing oil , fish oil , experimental animal model human . Therefore , represent original nutritional approach increase activity anticancer treatment enhance specificity toward tumor tissue .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Metastatic breast cancer require firstline taxanes anthracyclines base chemotherapy HER2 negative , HR positive Life expectancy &gt; 3 month ECOG Performance Status &lt; = 2 within 15 day randomization Measurable and/or evaluable disease accord RECIST criterion 1.1 Age &gt; = 18 year &lt; = 80 year Body Mass Index ( BMI ) &gt; 17 patient &lt; 70 year BMI &gt; 21 patient &gt; 70 year , within 15 day randomization Hepatic parameter : total bilirubin strictly normal , AST ALT &lt; = 3xULN ( 5 liver metastasis ) within 15 day randomization Signed write informed consent Triple negative breast cancer HER2 expression Symptomatic central nervous system metastases Previous chemotherapy metastatic breast cancer Obesity BMI &gt; 35 within 15 day randomization Presence another invasive cancer Uncontrolled Cardiac disease uncontrolled hypertension Milk protein intolerance Known food allergy fish Women childbearing potential use adequate contraceptive measure , pregnant breast feeding .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Metastatic Breast Cancer</keyword>
	<keyword>First-Line chemotherapy</keyword>
	<keyword>Taxane Anthracycline</keyword>
	<keyword>DHA</keyword>
	<keyword>PUFA</keyword>
	<keyword>Dietary supplementation</keyword>
	<keyword>First-Line Taxane Anthracycline base chemotherapy</keyword>
</DOC>